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Objective: Although the Short Form Health Survey version-2.0 (SF-36v2) is widely used since 2000, the
researchers and clinicians in Turkey have been still using the original version. However, the original
version includes many deﬁciencies and the SF-36v2 was introduced aiming to correct these deﬁciencies.
The purpose of this study is to indicate differences between SF-36 and SF-36v2 and the present cross
cultural adaptation, reliability and validity of the SF-36v2.
Patients and methods: The SF-36v2 was cross culturally adapted to Turkish and the measurement
properties of the Turkish version of the SF-36v2 were tested in 50 patients (19 males; mean ± SD age:
36.9 ± 14.6 years; range: 16e65 years, BMI; 24.1 ± 4.6) with a variety of musculoskeletal pathologies.
Intraclass correlation coefﬁcients (ICC) were used to estimate the test-retest reliability. Construct validity
was analyzed with SF-36v2 and EuroQol Group (EQ-5D). The distribution of ceiling and ﬂoor effects was
determined.
Results: During the cross-cultural adaptation process many changes were made. The Turkish SF-36v2
subscales showed excellent test-retest reliability which was ranged 0.80 to 0.95. The highest correla-
tion was found between SF-36v2-PCS and SF-36v2-PF (r ¼ 0.75), the lowest correlation was found be-
tween SF-36v2-PCS and SF-36v2-MH (r ¼ 0.05). The correlations between EQ-5D and SF-36v2 subscales
ranged from 0.10 (SF-36v2 eVT) to 0.46 (SF-36v2 eRE). We observed no ceiling and ﬂoor effects.
Conclusion: The cultural adaptation of the SF-36v2 was successful. The SF-36v2 has sufﬁcient reliability
and validity to measure a variety of musculoskeletal pathologies for Turkish-speaking individuals.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
The Short Form 36 (SF-36) is a health survey which includes 36
questions. It involves 8 different assessments of functional health
and well-being evaluation and also psychometrically calculated
measurements of mental and physical health. It is a general scale
which is not speciﬁc for any kind of age, disease or treatment
group.1 It is used for more than 200 disease or conditions such as
musculoskeletal conditions, neuromuscular conditions, osteoar-
thritis, psychiatric conditions, spinal injuries, trauma.2 Translations
of the SF-36 have become the topic of 500 publisher's andciation of Orthopaedics and
s and Traumatology. Publishing seresearcher's studies from 22 different countries. More than 10
studies have been conducted in 13 different countries.1
Although the SF-36 is widely used, it has been reported some
deﬁciencies. The SF-36 version 2 (SF-36v2) has been introduced to
correct deﬁciency of the SF-36. In 1996, after careful quantitative
and qualitative studies, it has been implemented by Ware et al.3,4
Brieﬂy the SF-36v2 involves some important changes. In-
structions are improved, questions are shortened, more familiar,
less obscure and simpliﬁed words are used, design of the form is
improved to make it easier to complete, read faster, and reduce
missing responses. Fourth and ﬁfth questions that evaluate physical
and emotional function, two level response orders of seven items
transformed into ﬁve level response orders. Ninth question that
evaluate mental health and vitality, six level response order
shortened into ﬁve response in order to simplify the answer.3,4
Turkish version of the SF-36 published in 1999 has been widely
used in researchers and clinicians.5 However, the existing Turkishrvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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different linguistic versions have been applied in the studies. We
think that is due to the missing of cross-cultural adaptation.
However, before using such an outcome measurement in a com-
munity, they need to be translated and culturally adapted, given
that the majority of these scores reﬂect the characteristics of the
language and the social culture of the community in which they
were established. For instance, even though “block” is a measure-
ment unit in United States, it was translated to “sokak” in Turkish
version which is not measurement unit in Turkey. In addition to
cross cultural adaptation, the reliability and validity of the Turkish
version of the SF-36 was only conducted patients with rheumotid
arthritis which is limited for patients with orthopedic pathologies.
There is no available cross culturally adapted SF-36v2 for
Turkish population. The purpose of the study is to introduce dif-
ferences between SF-36 and SF-36v2 and the cross cultural adap-
tation, reliability and validity of the SF-36v2.Patients and methods
Fifty patients with variety of musculoskletal pathologies were
recruited from the Istanbul University, Istanbul School of Medicine,
Department of Orthopedics. The inclusion criteria were: (1) 16
years or older; (2) presence of any musculoskletal problem; and (3)
no treatment between the test-retest assessments. The exclusion
criteria were: (1) inability to complete the forms as a result of
cognitive impairment; (2) illiteracy or lack of understanding of
Turkish; (3) the presence of neurologic disorders. Cross cultural
adaptation was held by two physical therapists and an orthopedic
surgeon. The patients were answered the SF-36v2 and EuroQol
Group (EQ-5D) for construct validity and SF-36v2 twice for the test-
retest reliability.Table 1
Patient demographics.
N (%)
Education
Primary school 9 (18)
Middle school 4 (8)
High school 20 (40)
University 17 (34)
Profession
Housewifes 17 (34)
Teacher 3 (6)
Student 12 (24)
Blue collar 5 (10)
White collar 7 (14)
Retired 6 (12)
Diagnosis
Meniscus\ACL\PCL injury 10 (20)
Spinal pathologies 9 (18)
Lateral epicondylitis 2 (4)
Carpal tunnel syndrome 1 (2)
Frozen shoulder\shoulder dislocation 5 (10)
Hallux valgus 4 (8)
Osteoarthritis 3 (6)
Osteosarcoma 1 (2)
Fibromyalgia 2 (4)
_Impingement syndrome\rotator cuff tear 2 (4)
Plantar fasciitis 2 (4)
Patella femoral pain syndrome 3 (6)
Pes planus 1 (2)
Fractures 2 (4)
Kienbock's disease 1 (2)
Hip arthroplasty 1 (2)
Bone marrow edema 1 (2)
Abbreviations: ACL: Anterior cruciate ligament, PCL: Posterior cruciate ligament.Short Form Health Survey (SF-36) and Short Form Health Survey
version-2.0 (SF-36v2)
The SF-36 is a multidimensional questionnaire that assesses
eight different aspects of health. It is generic by nature which
means that it, as opposed to disease-speciﬁc measures, can be used
to measure and compare outcomes across different diseases and
treatments. The SF-36 is a 36 item questionnaire that measures
eight multi-item dimensions of health: physical functioning (10
items) social functioning (2 items) role limitations due to physical
problems (4 items), role limitations due to emotional problems (3
items), mental health (5 items), energy/vitality (4 items), pain (2
items), and general health perception (5 items). For each dimen-
sion item scores are coded, summed, and transformed on to a scale
from 0 (worst possible health state measured by the questionnaire)
to 100 (best possible health state). Two standardized summary
scores can also be calculated from the SF-36; the physical
component summary (PCS) and the mental health component
summary (MCS).
In 1996, a new version of the questionnaire (SF-36v2) was
introduced which included improvements in the instructions, the
wording of some of the items, and the number of response op-
tions for two of the eight scales.3,4 Several general population
studies have conﬁrmed the improved precision, reliability, and
validity of the SF-36v2 over the original version.6,7 Version 2.0 of
the SF-36 Health Survey is a product of ﬁfteen years of research
and the experience documented in a wide variety of
publications.4EuroQol group (EQ-5D)
EQ-5D is a standardized instrument for use as a measure of
health outcome. Applicable to a wide range of health conditions
and treatments, it provides a simple descriptive proﬁle and a single
index value for health status. EQ-5D is primarily designed for self-
completion by individuals. It is cognitively simple, taking only a few
minutes to complete. Instructions to respondents are included in
the questionnaire.8Statistical analysis
All statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS) ver. 20.0 (SPSS Inc., Chicago,
IL, USA). The agreed level of signiﬁcance was p < 0.05. Descriptive
statistics were calculated for all variables. This included frequency
counts and percentages for nominal variables and measures of
central tendency (means, medians) and dispersion (standard de-
viations, ranges) for continuous variables. The Kolmogor-
oveSmirnov test was used to assess the distribution. The
measurement properties were analyzed in this study for test-retest
reliability, construct validity as well as ceiling and ﬂoor effects.
The test-retest reliability, which is a measure of stability or
reproducibility, represents a scale's capability of providing consis-
tent results when administered on separate occasions9,10 To
determine the test-retest reliability, 50 patients were asked to
complete the SF-36v2 3e7 days after the ﬁrst assessment. To
minimize the risk of short-term clinical change, no treatments were
provided during this period. Intraclass correlation coefﬁcients
(ICCs) were calculated using a 2-way, mixed-model. Values of 0.4 or
greater were considered satisfactory (r ¼ 0.81e1.0, excellent;
0.61e0.80, very good; 0.41e0.60, good; 0.21e0.40, fair; and
Table 3
The correlation between the SF-36v2 subscales and EQ-5D.
SF36 (PCS) SF36 (MCS) EQ-5D
SF-36v2 (PF) 0.75* 0.10 0.36*
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score retains its intended meaning and interpretation.11 In our
study, the construct validity of the Turkish SF-36v2 was analyzed
based on its correlation with SF-36v2 subscales and the EQ-5D.SF-36v2 (RP) 0.71* 0.17 0.25
SF-36v2 (BP) 0.72* 0.16 0.22
SF-36v2 (GH) 0.61* 0.18 0.15
SF-36v2 (VT) 0.36* 0.57* 0.10
SF-36v2 (SF) 0.25 0.57* 0.17
SF-36v2 (RE) 0.15 0.73* 0.46*
SF-36v2 (MH) 0.05 0.85* 0.24
SF-36v2(PCS) e e 0.20
SF-36v2 (MCS) e e 0.26
Abbreviations: SF-36v2; the Short Form Health Survey version-2.0, BP, bodily pain;
GH, general health perceptions; MCS, mental component scale; MH, mental health;
PCS, physical component scale; PF, physical functioning; RE, emotional role func-
tioning; RP, physical role functioning; SF ¼ social function; VT ¼ vitality.
*Signiﬁcant (<0.05).Results
Table 1 provides the demographic and clinical characteristics of
the patients. The descriptive statistics for the scores at baseline and
at the second administration of the SF-36v2 were given in Table 2.
The measurement properties of the Turkish version of the CMS
(test-retest reliability, agreement, construct validity, and ﬂoor and
ceiling effects) were tested in 50 patients (19 males; mean ± SD
age: 36.9 ± 14.6 years; range: 16e65 years, BMI; 24.1 ± 4.6) with a
variety of musculoskletal pathologies. The duration of patients'
symptoms in the group surveyed was 31 ± 26.5 months. The
average ± SD interval between the 2 assessments was 3.6 ± 2.2
days. The test-retest assessment of the SF-36v2 subscales indicated
excellent reliability, with an ICC of 0.80e0.95 (Table 2). The highest
reliability was found between SF-36v2-PCS and SF-36v2-PF
(r ¼ 0.75), the lowest reliability was found between SF-36v2-PCS
and SF-36v2-MH (r ¼ 0.05). Correlations between EQ-5D and SF-
36v2 subscales ranged from 0.10 (SF-36v2 eVT) to 0.46 (SF-36v2
eRE) (Table 3).Discussion
The purpose of this paper was to introduce differences between
SF-36 and SF-36v2 to the researchers in Turkey and, the cross
cultural adaptation, reliability and validity of the SF-36v2. Based on
our sample, the cross cultural adaptation of the SF-36v2 was suc-
cessfully completed and the SF-36v2 demonstrated acceptable
levels of reliability and validity, to be used as a generic question-
naire for Turkish-speaking individuals with a variety of musculo-
skeletal problems.
SF-36v2 compare to SF-36 is easier to understand, administer.
Relative to the standard SF-36 improvements in the content and
layout of SF-36v2 included; improvements in some instructions
and questions to make the wording less ambiguous, double nega-
tive item of the SF-36 was reworded, and ﬁve level response sets in
place of dichotomous response choices for seven items in the two
role functioning scales.12 There is evidence to suggest that ﬁve level
response scales improve response rates over dichotomous response
categories, such as “yes/no”. Consequently the two SF-36 role
functioning scales have been changed from dichotomous scales toTable 2
The mean ± SD and the test-retest reliability of the SF-36v2.
Mean ± SD Test-retest reliability (ICC)
Test 1 Test 2
SF-36v2 (PF) 46.4 ± 8.9 48.4 ± 6.7 0.90
SF-36v2 (RP) 40.8 ± 11.1 43.7 ± 9.2 0.80
SF-36v2 (BP) 44.1 ± 9.2 46.1 ± 9.4 0.81
SF-36v2 (GH) 43.3 ± 10.6 44 ± 10.1 0.95
SF-36v2 (VT) 46.6 ± 9.4 48.6 ± 10.4 0.89
SF-36v2 (SF) 45.6 ± 10.3 46.4 ± 9.7 0.81
SF-36v2 (RE) 38.4 ± 9.9 38þ ± 11.5 0.84
SF-36v2 (MH) 39.7 ± 10.7 41.1 ± 4.7 0.91
SF-36v2 (PCS) 46.4 ± 9.6 48.7 ± 7.8 0.90
SF-36v2 (MCS) 40.7 ± 10.2 40.7 ± 11.4 0.91
Abbreviations: BP, bodily pain; GH, general health perceptions; MCS, mental
component scale; MH, mental health; PCS, physical component scale; PF, physical
functioning; RE, emotional role functioning; RP, physical role functioning; SF, social
function; VT, vitality,: SF-36v2; the Short Form Health Survey version-2.0,ICC,
intraclass correlation coefﬁcient.ﬁve point response categories thus increasing score precision
without increasing respondent liability. Speciﬁcally, SF-36v2 ach-
ieves a quadruple increase in the number of scale levels, and is
intended to produce a substantially smaller standard deviation, as
well as to reduce both ceiling and ﬂoor effects for both SF-36 role
scales. In addition, SF-36v2 includes algorithms for interval level
scoring for all eight scales ranging from 0 (for worse health) to 100
(best possible health as measured by the questionnaire) as well as
the same standardized scoring (mean ¼ 50, standard
deviation ¼ 10) for the SF-36 summary scores (PCS and MCS).
During the cross-cultural adaptation process many changes
weremade. In the present study, “yards”which is not a Turkish unit
used to deﬁne a distance being adapted to kilometers. However,
some patients still were unable to answer this question because
they were unaccustomed to describing walking distance. Instead,
they preferred to describe walking duration. The patients felt more
comfortable explaining distance as a minute to spent walking.
Therefore, we included distance and duration in the questionnaire.
Past 4 weeks is usually replace with “geçen 4 hafta” in Turkish
however, in our experience, we felt that the patients prefer “son 1
aydır” instead of “geçen 4 hafta.” In question 3, the patients were
being asked if they can participate “in strenuous sports” but there
was no explanation or any example of what is strenuous sports. We
add “futbol e basketbol” as an example of strenous sports to make
it the question clearer. Moderate activities was described such as
“bowling, or playing golf” but these are not very usual activities in
Turkey so we used “masa tenisi” and “bilardo” instead of “bowling
and golf”. In addition, in question 4, “bodily pain”may be translated
as “vücut agrısı” but it is uncomman term in Turkish so we only
used “agrı” instead of “vücut agrısı.” Similarly, “physical” was
translated as a “bedensel.” We changed it as “ﬁziksel” since it is
widely used and a better option for this translation. Lastly, we
prefer translating activity as “aktivite” instead of “etkinlik.”
While people were ﬁlling out the form, they usually had difﬁ-
culties in understanding and answering at some speciﬁc parts.
Especially part 4 and part 5 questions which found confusing by
patients. Most people were not sure about what means of these
questions. In addition, it was taking more time for answering these
question compared to the others. Consequently, “Hede-
ﬂediginizden daha azını mı gerçekles¸tirdiniz?” was changed to
“_Isteklerinizi gerçekles¸tirmekte azalma oldu mu”? In order to
simplify the statements of question 4 and 5 “_Is¸inizi veya diger
etkinliklerinizi her zamanki kadar dikkatli yapamıyor muydunuz?”
was changed to “_Is¸inizde ya da diger aktivitelerinizde daha dik-
katsiz miydiniz?” and “_Is¸ veya diger etkinliklerinizde kısıtlanma
oldu mu?” was converted to “_Is¸ veya diger aktiviteleriniz kısıtlandı
mı?” People who ﬁll out the form had troubles in understanding
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yanlıs¸” “çogunlukla dogru/yanlıs¸.” In order to clarify these confused
statements,“kesinlikle katılıyorum/katılmıyorum” and “çogunlukla
katılıyorum/katılmıyorum” were used. In addition, the patients
found uncertain of the statement which was “Diger insanlardan
biraz daha kolay hastalanıyorum” so it was converted to “Diger
insanlardan daha kolay hastalandıgımı düs¸ünüyorum” (Appendix).
Psycometric properties of the SF-36v2 have been shown in
many different patients population such as rheumatoid arthritis,
tuberculosis, low back pain in the literature.13e15 We did not
include any speciﬁc patient population in the study due to the
necessity of cross cultural adaptation. Therefore, it basically aim to
compare our reliability and validity analysis in the literature. The
latest and comprehensive study was reported by Klooster et al, in
Duch population with rheumatoid arthritis.15 In Duch version, the
reliability was reported with internal consistency. We presented
the test-retest reliability which is considered excellent with all
subscales of the SF-36v2 (Table 2). Internal construct validity of the
Duch version of SF-36v2 ranged from 0.79 to 0.95 for subscales and
the correlation with SF-36v2 PCS and MCS ranges from 0.19 to 0.91.
Internal construct validity was reported in this study between SF-
36v2 subscales and SF-36v2 PCS and MCS. The highest correlation
was found between SF-36v2 PCS and SF-36v2 PF which was nor-
mally expected and found te lowest correlation nd between SF-
36v2 PCS and SF-36v2 MH. External construct validity was esti-
mated with EQ-5D. The highest correlationwas found between EQ-
5D and SF-36V2 role emotional (r ¼ 046). We believe that this can
be explained by the content of the questions of EQ-5D which is
more related to psychology.
The primary limitations of our study included the untested
statistical power and small sample size. However, previous vali-
dation studies have used similar numbers of individuals, and the
sample size was large enough to reach statistical signiﬁcance.
Nevertheless, the Turkish SF-36v2 should be applied to larger
populations to evaluate its reliability, validity, responsiveness, and
minimal clinically important differences in patients with various
diagnoses.
A cultural adaptation of the SF-36v2 and its reliability and val-
idity were successfully conducted. The original SF-36 has still beenusing in Turkey without cross cultural adaptation which was
already disused in the world since 15 years. Therefore, we strongly
advice of using cross culturally adapted, reliable and valid Turkish
SF-36v2 in Turkish population.Appendix A. Supplementary data
Supplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.aott.2016.08.013.References
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